🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the efficacy and safety of sunvozertinib as neoadjuvant therapy i...
Status
Active Not Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2024-10-17
Trial ID
NCT07274761
Treatments Being Tested
This study will treat patients with advanced NSCLC with EGFR or HER2 mutati...
Status
Active Not Recruiting
Location
University of California, San Diego (UCSD) - Moores Cancer Center
Start Date
2019-07-09
Trial ID
NCT03974022
Treatments Being Tested
This is a Phase II, single-arm, multi-center clinical study to evaluate the...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2021-07-19
Trial ID
NCT05712902
Treatments Being Tested
To assess the efficacy and safety of sunvozertinib versus placebo as adjuva...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-12-01
Trial ID
NCT07182682
Treatments Being Tested
This study is designed to evaluate safety and anti-tumor activity of DZD600...
Status
Recruiting
Location
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
Start Date
2025-05-13
Trial ID
NCT06905197
Treatments Being Tested
To access the anti-tumor efficacy, safety and tolerability of Sunvozertinib...
Status
Recruiting
Location
West China Hospital of Sichuan University
Start Date
2024-02-29
Trial ID
NCT06195189
Treatments Being Tested
This is a phase 3, open-label, randomized, multi-center study assessing the...
Status
Active Not Recruiting
Location
OPN Healthcare, Inc.
Start Date
2022-12-13
Trial ID
NCT05668988
Treatments Being Tested
This is a phase II, open-label, single-arm, single-center clinical study to...
Status
Recruiting
Location
Hunan Cancer Hospital
Start Date
2024-07-01
Trial ID
NCT06355609
Treatments Being Tested
This is a single-arm, phase 2 study to investigate the efficacy and safety ...
Status
Recruiting
Location
Second Xiangya Hospital of Central South University
Start Date
2025-02-18
Trial ID
NCT06864624
Treatments Being Tested
This is a phase II, open-label, single-arm, single-center clinical study to...
Status
Recruiting
Location
Hunan Cancer Hospital
Start Date
2024-07-01
Trial ID
NCT06348927
Treatments Being Tested